Feb 19, 2026 07:00AM
Jan 9, 2026 07:02AM
Jan 9, 2026 07:00AM
Dec 2, 2025 08:30AM
Oct 30, 2025 07:00AM
Oct 17, 2025 07:01AM
Oct 17, 2025 07:00AM CHMP Recommends EU Approval of BRINSUPRI™ (brensocatib) for the Treatment of Non-Cystic Fibrosis Bronchiectasis
Oct 16, 2025 07:00AM
Oct 16, 2025 07:00AM
Sep 11, 2025 08:18AM
Sep 10, 2025 09:16AM
Sep 8, 2025 07:22AM
Aug 14, 2025 05:55AM
Aug 13, 2025 09:54AM RBC Capital on Insmed's (INSM) Brinsupri Approval: 'Stock PT To $138.00, Buyers Into The Launch'
Aug 13, 2025 05:19AM
Aug 12, 2025 02:49PM
Aug 12, 2025 11:36AM
Aug 12, 2025 11:34AM
Aug 7, 2025 07:00AM
Jun 11, 2025 10:27PM
Jun 11, 2025 10:25PM Insmed Announces Pricing of $750 Million Public Offering of Common Stock
Jun 11, 2025 04:01PM
Jun 11, 2025 04:01PM
Jun 10, 2025 12:25PM
Jun 10, 2025 09:31AM
Jun 10, 2025 07:01AM
Jun 10, 2025 07:00AM
May 21, 2025 04:05PM Brensocatib Shows Consistent Efficacy and Safety Across Three Prespecified Subgroups in New Data from Landmark ASPEN Study
May 8, 2025 07:00AM
Apr 23, 2025 05:00PM
Apr 23, 2025 05:00PM
Apr 12, 2025 04:00AM
Mar 25, 2025 08:00AM
Feb 24, 2025 08:04AM
Feb 24, 2025 08:00AM Insmed Announces that FDA Does Not Currently Plan to Hold Advisory Committee Meeting to Discuss New Drug Application for Brensocatib in Patients with Bronchiectasis
Feb 21, 2025 09:07AM
Feb 20, 2025 07:00AM
Feb 6, 2025 08:03AM
Feb 6, 2025 08:00AM
Jan 10, 2025 08:00AM
Dec 22, 2024 04:00AM
Oct 31, 2024 07:00AM Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update
Oct 8, 2024 04:06PM
Oct 8, 2024 04:05PM
Aug 8, 2024 07:00AM
Jul 3, 2024 09:03AM
May 30, 2024 04:05PM
May 30, 2024 08:00AM
May 30, 2024 08:00AM Insmed Announces Pricing of $650 Million Public Offering of Common Stock
May 29, 2024 05:49AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All